The main findings of the case study were verified using flow cytometry and real-time polymerase chain reaction (RT-PCR) analysis.<h4>Results</h4>Through systematic analysis, we found that CD62L-CD86+ myeloid dendritic cells (DCs) were key intermediate factors that increased the risk of sepsis with enhanced gut microbiota. This evidence concerns the gene SELL and Sepsis.